| Literature DB >> 29157081 |
Guan-Sheng Liu1, Hongyan Zhu1, Wen-Feng Cai2, Xiaohong Wang1, Min Jiang3, Kobina Essandoh1, Elizabeth Vafiadaki4, Kobra Haghighi1, Chi Keung Lam1, George Gardner1, George Adly1, Persoulla Nicolaou1, Despina Sanoudou4, Qiangrong Liang5, Jack Rubinstein3, Guo-Chang Fan1, Evangelia G Kranias1,4.
Abstract
HSPB6/Hsp20 (heat shock protein family B [small] member 6) has emerged as a novel cardioprotector against stress-induced injury. We identified a human mutant of HSPB6 (HSPB6S10F) exclusively present in dilated cardiomyopathy (DCM) patients. Cardiac expression of this mutant in mouse hearts resulted in remodeling and dysfunction, which progressed to heart failure and early death. These detrimental effects were associated with reduced interaction of mutant HSPB6S10F with BECN1/Beclin 1, leading to BECN1 ubiquitination and its proteosomal degradation. As a result, autophagy flux was substantially inhibited and apoptosis was increased in HSPB6S10F-mutant hearts. In contrast, overexpression of wild-type HSPB6 (HSPB6 WT) not only increased BECN1 levels, but also competitively suppressed binding of BECN1 to BCL2, resulting in stimulated autophagy. Indeed, preinhibition of autophagy attenuated the cardioprotective effects of HSPB6 WT. Taken together, these findings reveal a new regulatory mechanism of HSPB6 in cell survival through its interaction with BECN1. Furthermore, Ser10 appears to be crucial for the protective effects of HSPB6 and transversion of this amino acid to Phe contributes to cardiomyopathy.Entities:
Keywords: BECN1; HSPB6; autophagy; heart failure; human mutation
Mesh:
Substances:
Year: 2018 PMID: 29157081 PMCID: PMC5846551 DOI: 10.1080/15548627.2017.1392420
Source DB: PubMed Journal: Autophagy ISSN: 1554-8627 Impact factor: 16.016